What is the recommended dose and duration of oral amoxicillin for treating a patient with a suspected or confirmed Enterococcus (E.) faecalis infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 24, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Oral Amoxicillin for E. faecalis Treatment

For confirmed E. faecalis infections, oral amoxicillin monotherapy is NOT recommended as standard treatment—intravenous ampicillin (equivalent to amoxicillin) at 2 g every 4 hours (12 g/24 hours total) combined with either gentamicin or ceftriaxone for 4-6 weeks is the guideline-directed therapy. 1

Standard IV Treatment Regimen (Not Oral)

The established treatment for E. faecalis infections requires intravenous therapy, not oral:

First-Line Combination Therapy

  • Ampicillin 2 g IV every 4 hours (12 g/24 hours in 6 divided doses) PLUS gentamicin 3 mg/kg/day IV or IM in 1 dose for 2-6 weeks for aminoglycoside-susceptible strains 2, 1
  • Duration depends on infection site: 4 weeks for native valve endocarditis with symptoms <3 months, 6 weeks for symptoms ≥3 months or prosthetic valve involvement 2

Alternative for High-Level Aminoglycoside Resistance (HLAR)

  • Ampicillin 2 g IV every 4 hours (12 g/24 hours) PLUS ceftriaxone 2 g IV every 12 hours (4 g/24 hours) for 6 weeks 2, 1, 3
  • This combination is effective against E. faecalis strains with and without HLAR and has significantly lower nephrotoxicity (0% vs 23% with aminoglycoside regimens) 3

Limited Role for Oral Therapy

Transition to Oral After Initial IV Treatment

  • Oral antibiotic therapy may be considered only in highly selected stable patients with left-sided IE caused by E. faecalis after initial intravenous antibiotics, if TEE shows no paravalvular infection, frequent follow-up is assured, and repeat TEE can be performed 1-3 days before completion 2
  • This is a Class IIb recommendation (may be considered), not standard practice 2

Prophylaxis Context Only

  • Single-dose oral amoxicillin 2-3 g provides 100% protection in experimental endocarditis prophylaxis models 4
  • However, this applies to prophylaxis before procedures, NOT treatment of established infection 4

Critical Monitoring Parameters

  • Monitor renal function weekly (twice weekly if using aminoglycosides) by assessing creatinine clearance 2, 1
  • Gentamicin levels: target 1-hour serum concentration ≈3 μg/mL and trough <1 μg/mL when using divided dosing 2
  • Avoid streptomycin if creatinine clearance <50 mL/min 2

Common Pitfalls and How to Avoid Them

  • Never use oral monotherapy for active E. faecalis infection—combination IV therapy is essential for synergistic bactericidal activity 1
  • Do not shorten therapy below recommended durations (4-6 weeks depending on clinical scenario) 1
  • Always test for high-level aminoglycoside resistance—if present, switch to ampicillin-ceftriaxone combination rather than ampicillin-gentamicin 2, 1
  • Administer gentamicin in divided doses (every 8 hours), not once daily, for enterococcal infections despite once-daily dosing being used for other infections 2
  • Do not obtain blood cultures after starting antibiotics in patients with known valvular heart disease and unexplained fever 2

Penicillin Allergy Alternative

  • Vancomycin 30 mg/kg/day IV in 2 divided doses (target trough ≥20 mg/L) PLUS gentamicin 3 mg/kg/day for 6 weeks 2, 3

References

Guideline

Enterococcus faecalis Infection Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Ampicillin-Based Regimen for Treatment of Chronic Prostatitis Caused by Enterococcus faecalis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.